|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-2-28
|
|
pubmed:abstractText |
Deletion polymorphism of the UDP-glucuronosyltransferase 2B17 (UGT2B17) gene has been associated with an increased prostate cancer risk in two previous independent studies. Here we determine the risk in a large-scale population-based case-control study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0270-4137
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
571-5
|
|
pubmed:meshHeading |
pubmed-meshheading:18247404-Aged,
pubmed-meshheading:18247404-Case-Control Studies,
pubmed-meshheading:18247404-Gene Deletion,
pubmed-meshheading:18247404-Genetic Predisposition to Disease,
pubmed-meshheading:18247404-Genotype,
pubmed-meshheading:18247404-Glucuronosyltransferase,
pubmed-meshheading:18247404-Humans,
pubmed-meshheading:18247404-Logistic Models,
pubmed-meshheading:18247404-Male,
pubmed-meshheading:18247404-Middle Aged,
pubmed-meshheading:18247404-Polymorphism, Genetic,
pubmed-meshheading:18247404-Prostatic Neoplasms,
pubmed-meshheading:18247404-Risk Factors,
pubmed-meshheading:18247404-Sweden
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The UGT2B17 gene deletion is not associated with prostate cancer risk.
|
|
pubmed:affiliation |
Department of Urology, Karolinska University Hospital, Stockholm, Sweden. mats.j.olsson@karlolinska.se
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
